Discontinuation report CISATRACURIUM BESYLATE INJECTION

Last updated on 2019-03-28 History
Report ID 79693
Drug Identification Number 02425718
Brand name CISATRACURIUM BESYLATE INJECTION
Common or Proper name Cisatracurium Besylate Injection
Company Name PFIZER CANADA ULC
Active Ingredient(s) CISATRACURIUM
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 10mL
ATC code M03AC
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-03-25
Remaining supply date 2019-03-25
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-03-28 French Compare
v1 2019-03-28 English Compare